高级检索
当前位置: 首页 > 详情页

Different response of the oxygen pathway in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy versus balloon pulmonary angioplasty

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, [2]National Center for Respiratory Medicine, Beijing, China [3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China, [4]National Clinical Research Center for Respiratory Diseases, Beijing, China, [5]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China, [6]Department of Pulmonary and Critical Care Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China, [7]State Key Laboratory of Medical Molecular Biology, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
出处:
ISSN:

关键词: balloon pulmonary angioplasty (BPA) pulmonary endarterectomy (PEA) chronic thromboembolic pulmonary disease oxygen pathway effect

摘要:
BackgroundOxygen pathway limitation exists in chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary endarterectomy (PEA) and balloon pulmonary angioplasty (BPA) are two effective interventions for CTEPH, but their effects and comparison of these two interventions on the oxygen pathway are not well demonstrated. MethodsCTEPH patients with available pulmonary function test, hemodynamics, and blood gas analysis before and after the interventions were included for comparison of oxygen pathway in terms of lung ventilation, lung gas exchange, oxygen delivery, and oxygen extraction between these two interventions. ResultsThe change in the percentage of the predicted forced expiratory volume in the 1 s (-3.4 +/- 12.7 vs. 3.8 +/- 8.7%, P = 0.006) and forced vital capacity (-5.5 +/- 13.0 vs. 4.2 +/- 9.9%, P = 0.001) among the PEA group (n = 24) and BPA group (n = 46) were significantly different. Patients in the PEA group had a significant increase in their arterial oxygen saturation (from 92.5 +/- 3.6 to 94.6 +/- 2.4%, P = 0.022), while those in the BPA group had no change, which could be explained by a significant improvement in ventilation/perfusion (-0.48 +/- 0.53 vs. -0.17 +/- 0.41, P = 0.016). Compared with patients post-BPA, patients post-PEA were characterized by higher oxygen delivery (756.3 +/- 229.1 vs. 628.8 +/- 188.5 ml/min, P = 0.016) and higher oxygen extraction (203.3 +/- 64.8 vs. 151.2 +/- 31.9 ml/min, P = 0.001). ConclusionPartial amelioration of the oxygen pathway limitations could be achieved in CTEPH patients treated with PEA and BPA. CTEPH patients post-PEA had better performance in lung gas exchange, oxygen delivery, and extraction, while those post-BPA had better lung ventilation. Cardiopulmonary rehabilitation may assist in improving the impairment of the oxygen pathway.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 心脏和心血管系统
JCR分区:
出版当年[2020]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, [2]National Center for Respiratory Medicine, Beijing, China [3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China, [4]National Clinical Research Center for Respiratory Diseases, Beijing, China, [5]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China, [6]Department of Pulmonary and Critical Care Medicine, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China,
通讯作者:
通讯机构: [1]Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China, [2]National Center for Respiratory Medicine, Beijing, China [3]Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing, China, [4]National Clinical Research Center for Respiratory Diseases, Beijing, China, [5]Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing, China,
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)